Kaposi's sarcoma and the use of oestrogen by male homosexuals

GESTRINONE IN THE TREATMENT OF MYOMAS.

Acta obstetricia et gynecologica Scandinavica·2017

Immunization with cytoplasmic repetitive antigen and flagellar repetitive antigen of Trypanosoma cruzi stimulates a cellular immune response in mice.

Parasitology·2004

Effect of previous hormone replacement therapy on endometrial polyps during menopause.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2004

Proliferation kinetics in adenomyosis during the menstrual cycle and during oral contraceptive use.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2004

Decreased humoral and pathologic responses in undernourished mice infected with Schistosoma mansoni.

Parasitology research·2004

Proliferation profile of endometrial polyps in post-menopausal women.

Maturitas·2001

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

PTPN1 downregulation contributes to pachymic acid-induced mitochondrial apoptosis in colorectal cancer cells.

Frontiers in oncology·2026

Bardoxolone Methyl Induces Partially Caspase-dependent Apoptosis of Oral Squamous Cell Carcinoma Cells.

Anticancer research·2026

Effects of a Benzimidazolium Salt on Colorectal Cancer Cells: Involvement of Apoptosis and Autophagy.

Molecules (Basel, Switzerland)·2026

Mechanistic Profiling of Phenethyl Isothiocyanate in CCRF-CEM Acute Lymphoblastic Leukemia Cells.

Pharmaceuticals (Basel, Switzerland)·2026

Antiproliferative, Cytotoxic, and Antimigratory Effects of Licochalcone A in Ishikawa Endometrial Cancer Cells.

Pharmaceuticals (Basel, Switzerland)·2026

Plant-Derived Polyphenols in Osteoarthritis: Mechanisms, Delivery Systems, and Therapeutic Synergy.

Life (Basel, Switzerland)·2026

Related Experiment Videos

Kaposi's sarcoma and the use of oestrogen by male homosexuals

Related Concept Videos

GESTRINONE IN THE TREATMENT OF MYOMAS.

Immunization with cytoplasmic repetitive antigen and flagellar repetitive antigen of Trypanosoma cruzi stimulates a cellular immune response in mice.

Effect of previous hormone replacement therapy on endometrial polyps during menopause.

Proliferation kinetics in adenomyosis during the menstrual cycle and during oral contraceptive use.

Decreased humoral and pathologic responses in undernourished mice infected with Schistosoma mansoni.

Proliferation profile of endometrial polyps in post-menopausal women.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

PTPN1 downregulation contributes to pachymic acid-induced mitochondrial apoptosis in colorectal cancer cells.

Bardoxolone Methyl Induces Partially Caspase-dependent Apoptosis of Oral Squamous Cell Carcinoma Cells.

Effects of a Benzimidazolium Salt on Colorectal Cancer Cells: Involvement of Apoptosis and Autophagy.

Mechanistic Profiling of Phenethyl Isothiocyanate in CCRF-CEM Acute Lymphoblastic Leukemia Cells.

Antiproliferative, Cytotoxic, and Antimigratory Effects of Licochalcone A in Ishikawa Endometrial Cancer Cells.

Plant-Derived Polyphenols in Osteoarthritis: Mechanisms, Delivery Systems, and Therapeutic Synergy.

Related Experiment Videos

Kaposi's sarcoma and the use of oestrogen by male homosexuals

Related Concept Videos

Related Articles